SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales surged to Rs. 69.84 millions, up 27.42% for the June 2026 quarter as against Rs. 54.81 millions during the corresponding quarter previous year.The Net Loss for the quarter ended June 2026 is Rs. -24.86 millions as compared to Net Loss of Rs. -53.24 millions of corresponding quarter ended June 2025 Operating profit Margin for the quarter ended June 2026 improved to 9.83% as compared to -20.75% of corresponding quarter ended June 2025


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202606 202506 % Var 202606 202506 % Var 202603 202503 % Var
Sales 69.84 54.81 27.42 69.84 54.81 27.42 237.32 433.12 -45.21
Other Income 1.57 0.12 1208.33 1.57 0.12 1208.33 20.26 7.09 185.75
PBIDT 9.83 -20.75 -147.37 9.83 -20.75 -147.37 -34.23 -143.21 -76.10
Interest 18.81 16.50 14.00 18.81 16.50 14.00 70.86 59.14 19.82
PBDT -8.98 -37.25 -75.89 -8.98 -37.25 -75.89 -105.09 -202.35 -48.07
Depreciation 15.88 15.99 -0.69 15.88 15.99 -0.69 64.23 66.89 -3.98
PBT -24.86 -53.24 -53.31 -24.86 -53.24 -53.31 -169.32 -269.24 -37.11
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -24.86 -53.24 -53.31 -24.86 -53.24 -53.31 -169.32 -269.39 -37.15
Equity 215.61 215.61 0.00 215.61 215.61 0.00 215.61 215.61 0.00
PBIDTM(%) 14.08 -37.86 -137.18 14.08 -37.86 -137.18 -14.42 -33.06 -56.38

Krebs Biochem.&Inds Share Price

53.49 0.00 (0.00%)
06-Aug-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1944.85
Dr. Reddys Labs. 1163.40
Cipla 1465.60
Lupin 2400.90
Zydus Lifesciences 1102.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: